2222:TSEKotobuki Spirits Co., Ltd. Analysis
Data as of 2026-06-13 - not real-time
SAR 27.18
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
Saudi Arabian Oil Company (2222.SR) is trading at SAR 27.18, comfortably above the computed support of SAR 26.90 and below the resistance of SAR 27.96, with the 20‑day SMA (27.55) sitting above both the 50‑day (27.47) and 200‑day (25.65) averages, indicating a bullish price structure. Fundamentally, the stock appears undervalued – its forward PE of 16.3 is well under the industry average of 21.5, and the DCF‑derived fair value of SAR 29.34 suggests an upside of roughly 11.5%.
Operationally, the company posted 8.8% revenue growth, a 57% gross margin, and a 21.9% ROE, while generating SAR 374 B of free cash flow, comfortably supporting its 4.99% dividend yield despite an 86% payout ratio. The market sentiment is extremely bullish (Fear‑Greed Index 89.86), volume is increasing, and beta is essentially neutral (-0.08), limiting systematic risk, though the high debt‑to‑equity of 21.6 signals leverage to monitor.
Operationally, the company posted 8.8% revenue growth, a 57% gross margin, and a 21.9% ROE, while generating SAR 374 B of free cash flow, comfortably supporting its 4.99% dividend yield despite an 86% payout ratio. The market sentiment is extremely bullish (Fear‑Greed Index 89.86), volume is increasing, and beta is essentially neutral (-0.08), limiting systematic risk, though the high debt‑to‑equity of 21.6 signals leverage to monitor.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 7/10
Key Factors
- Price near support with bullish SMA alignment
- MACD bearish histogram indicating short‑term caution
- Strong cash flow and high dividend yield
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Projected upside to DCF fair value (~11.5%)
- Analyst target median price SAR 30.4
- Sustained earnings growth and robust margins
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Consistent high ROE/ROA and low beta reducing market volatility
- Strategic diversification across upstream and downstream segments
- Attractive dividend yield with solid free cash flow support
Key Metrics & Analysis
Financial Health
Revenue Growth8.80%
Profit Margin21.80%
P/E Ratio17.6
ROE21.88%
ROA18.84%
Debt/Equity21.59
P/B Ratio4.3
Op. Cash FlowSAR507.1B
Free Cash FlowSAR374.1B
Industry P/E21.5
Technical Analysis
TrendBullish
RSI42.3
SupportSAR 26.90
ResistanceSAR 27.96
MA 20SAR 27.55
MA 50SAR 27.47
MA 200SAR 25.65
MACDBearish
VolumeIncreasing
Fear & Greed Index89.86
Valuation
Fair ValueSAR 29.34
Target PriceSAR 30.30
Upside/Downside11.48%
GradeUndervalued
TypeBlend
Dividend Yield4.99%
Risk Assessment
Beta-0.08
Volatility12.16%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.